Triastek Secures Strategic Financing to Advance 3D-Printed Oral Peptide Pipeline and Build Shanghai International R&D Center
Triastek (Nanjing) Pharmaceutical Technology Co., Ltd. (“Triastek”) announced the completion of a new strategic financing...
Triastek (Nanjing) Pharmaceutical Technology Co., Ltd. (“Triastek”) announced the completion of a new strategic financing...
Nanjing-based Triastek Inc., a pioneer in 3D-printed pharmaceutical formulations, has obtained Investigational New Drug (IND)...
China-based Triastek Inc., a pharmaceutical-focused 3D printing company, has announced receiving clinical approval in the...
China-based Triastek Inc., a pioneer in pharmaceutical 3D printing, announced positive outcomes from a clinical...
Triastek Inc., a China-based pharmaceutical company specializing in 3D printing technology, has entered into a...
Triastek Inc., a China-based pharmaceutical-focused 3D printing company, has entered into a partnership with fellow...
China-based Triastek Inc., a leader in pharmaceutical-focused 3D printing, has announced a strategic partnership with...
China-based Triastek Inc., a company at the forefront of pharmaceutical-focused 3D printing, has reportedly secured...
China-based Triastek Inc., a leading pharmaceutical-focused 3D printing company, has entered into a partnership with...
China-based Triastek Inc., a pharmaceutical 3D printing specialist, announced a partnership with US firm Eli...